Purchase Order FA301013P0028
Award Date 11/7/12
Potential Completion Date 11/9/12
Potential Value $40K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the purchase of VYSIS LSI IGH/BCL2 DUAL COLOR FUSION products. The $29,540.40 firm fixed-price purchase order was awarded by the Defense Health Agency, a component of the U.S. Department of Defense. The contract does not have a set-aside designation and is scheduled for completion on July 25, 2016. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has received...
- This is a delivery order issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $169,843.85 fixed-price award was made by the Department of Veterans Affairs Veterans Health Administration to provide "Cost Per Test Testing (Emergency)" services. The order does not have a set-aside designation. Abbott Molecular is a leading provider of molecular diagnostics products and services to federal...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide M2000 TESTINGS. The contract, which has a potential value of $234,860.24, was not set aside for any specific business category. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will perform the contract in Philadelphia, PA. This award is part of the Critical Analyzers,...
- The Defense Health Agency awarded Abbott Molecular Inc. a definitive firm fixed-price contract valued at $6.1 million on October 1, 2026, for molecular transplant, respiratory, and sexual health testing services supporting the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas. The contract extends through September 30, 2029, and was awarded without small business set-aside designation. Abbott Molecular, a subsidiary...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a $604,132.63 firm fixed price delivery order against an unspecified government-wide acquisition contract to provide Abbott Lease, Reagents and Supplies for M2000 Systems to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 located in Des Plaines, Illinois. The order has a period of performance through September 30, 2021 and was awarded on October 1, 2019 without a...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a delivery order valued at $12.0 million by Veterans Integrated Service Network 20 (VA Puget Sound Health Care System) on December 1, 2020, with an ultimate completion date of November 30, 2025. This firm fixed-price delivery order, issued under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule, does not utilize a small business set-aside designation. The award supports the VA's...
- This contract is a Blanket Purchase Agreement (BPA) Call awarded by the Defense Health Agency (DHA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract, valued up to $100,000.00, is for the provision of reagents and peripheral equipment. The award has a completion date of October 18, 2017 and utilizes a Firm Fixed Price pricing type. Abbott Molecular is an experienced federal contractor, having previously provided a range of molecular diagnostics equipment, reagents,...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a firm fixed-price purchase order valued at $121,043.36 by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract, awarded on June 21, 2024, with an ultimate completion date of February 1, 2025, provides Abbott M2000 System molecular diagnostic equipment and related supplies for HIV viral load and early infant diagnosis testing. The Abbott M2000 System is recognized by the World Health...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories and a leading provider of molecular diagnostic products, has been awarded a Delivery Order for reagents and consumables for laboratory tests under the In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule contract. The award, issued by Veterans Integrated Service Network 20 (a civilian component of the Department of Veterans Affairs), carries a ceiling value of approximately $5.0 million with firm fixed pricing. Performance will...
- The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a manufacturer of molecular diagnostics equipment and testing services. The $340,000.00 contract is for the provision of reagents and peripheral consumable supplies such as magnesium chloride, HER-2 DNA probe kits, and control slides. The contract does not have a set-aside designation. Abbott Molecular, a subsidiary of Abbott Laboratories, has provided a range of molecular...